Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6652956 | 0.99 | GRIN1 (0.64) | GRIN1 | |
| SCHEMBL6650457 | 0.97 | GRIN1 (0.64) | GRIN1 | |
| Bromide SCHEMBL6652277 | 0.96 | GRIN1 (0.62) | GRIN1 | |
| SCHEMBL6650258 | 0.94 | GRIN1 (0.69) | GRIN1 | |
| Bromide SCHEMBL6652922 | 0.93 | GRIN1 (0.67) | GRIN1 | |
| SCHEMBL2391875 | 0.86 | GRIN1 (0.70) | GRIN1 | |
| SCHEMBL8566071 | 0.86 | GRIN1 (0.57) | GRIN1 | |
| Bromide SCHEMBL6648847 | 0.85 | GRIN1 (0.69) | GRIN1 | |
| Hydrochloric Acid SCHEMBL8092018 | 0.85 | GRIN1 (0.56) | GRIN1 | |
| SCHEMBL5974311 | 0.84 | GRIN1 (0.61) | GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0853617-B1 | NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES | NOVARTIS AG (CH) | 2004-03-03 | — | — | EP | claimed |
| EP-0853617-A1 | NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES | Novartis AG (CH) | 1998-07-22 | — | — | EP | claimed |
| WO-1997008155-A1 | NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES | NOVARTIS AG (CH) | 1997-03-06 | — | — | WO | claimed |
| EP-0853617-B1 | NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES | NOVARTIS AG (CH) | 2004-03-03 | — | — | EP | disclosed |